help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marselli, L.
Right arrow Articles by Marchetti, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marselli, L.
Right arrow Articles by Marchetti, P.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 10 4974-4978
Copyright © 2001 by The Endocrine Society


Other Original Articles

Th2 Cytokines Have a Partial, Direct Protective Effect on the Function and Survival of Isolated Human Islets Exposed to Combined Proinflammatory and Th1 Cytokines

Lorella Marselli, Francesco Dotta, Salvatore Piro, Carmela Santangelo, Matilde Masini, Roberto Lupi, Massimo Realacci, Silvia del Guerra, Franco Mosca, Ugo Boggi, Francesco Purrello, Renzo Navalesi and Piero Marchetti

Dipartimento di Endocrinologia e Metabolismo, Sezione Metabolismo, Università di Pisa (L.M., M.M., R.L., S.D.G., R.N., P.M.), 56100 Pisa; Dipartimento di Scienze Cliniche, Università La Sapienza, Roma (F.D., C.S., M.R.), Roma; Cattedra di Endocrinologia e Patologia Costituzionale, Università di Catania (S.P., F.P.), Catania; and Dipartimento di Oncologia, Università di Pisa (F.M., U.B.), Pisa, Italy

Address all correspondence and requests for reprints to: Piero Marchetti, M.D., Dipartimento di Endocrinologia e Metabolismo, Ortopedia e Traumatologia, Medicina del Lavoro (Sezione Metabolismo), via Paradisa 2, Ospedale Cisanello, 56100 Pisa, Italy. E-mail: marchant{at}immr.med.unipi.it

Abstract

Studies in rodents have suggested that Th2 and Th3 cytokines can be effective in reducing proinflammatory and Th1 cytokine-induced islet damage. Whether this is the case with human islets and might be due to a direct action of Th2 and Th3 cytokines is not known. In the present study, we evaluated whether Th2 (500 U/ml IL-4 plus 100 U/ml IL-10) or Th3 (5 ng/ml TGF-1ß) cytokines may prevent the derangements induced on isolated human islets by prolonged (12 or 72 h) exposure to combined proinflammatory (50 U/ml IL-1ß, 1000 U/ml TNF {alpha}) and Th1 (1000 U/ml interferon {gamma}) cytokines. Compared with control islets, cells preincubated for 12 or 72 h with proinflammatory and Th1 cytokines showed a significant decrease of glucose-stimulated insulin secretion and a significant increase of nitrites production. The addition of IL-4 plus IL-10 or TGF-1ß in the medium prevented these cytostatic effects in the 12-h incubation experiments, but not after the 72-h exposure period. IL-1ß, interferon {gamma}, and TNF {alpha} caused no major change in either islet cell survival or Bcl-2 and Bax mRNA expression after a 12-h incubation; however, a marked increase in the amount of dead cells, with a major decrease of Bcl-2 mRNA expression, was observed after 72 h. The presence of Th2, but not of Th3, cytokines significantly reduced ß-cell death, without any major effect on Bcl-2 and Bax mRNA expression. These results suggest that Th2 and (at lower extent) Th3 cytokines may have a partial, direct protective effect on isolated human islets exposed to the cytostatic and cytotoxic action of proinflammatory and Th1 cytokines.




This article has been cited by other articles:


Home page
EndocrinologyHome page
S. Poncin, B. Lengele, I. M. Colin, and A.-C. Gerard
Differential Interactions between Th1/Th2, Th1/Th3, and Th2/Th3 Cytokines in the Regulation of Thyroperoxidase and Dual Oxidase Expression, and of Thyroglobulin Secretion in Thyrocytes in Vitro
Endocrinology, April 1, 2008; 149(4): 1534 - 1542.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Dotta, S. Censini, A. G. S. van Halteren, L. Marselli, M. Masini, S. Dionisi, F. Mosca, U. Boggi, A. O. Muda, S. D. Prato, et al.
Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients
PNAS, March 20, 2007; 104(12): 5115 - 5120.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. Welsh, M. Cnop, I. Kharroubi, M. Bugliani, R. Lupi, P. Marchetti, and D. L. Eizirik
Is There a Role for Locally Produced Interleukin-1 in the Deleterious Effects of High Glucose or the Type 2 Diabetes Milieu to Human Pancreatic Islets?
Diabetes, November 1, 2005; 54(11): 3238 - 3244.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
E Anastasi, C Santangelo, A Bulotta, F Dotta, B Argenti, C Mincione, A Gulino, M Maroder, R Perfetti, and U Di Mario
The acquisition of an insulin-secreting phenotype by HGF-treated rat pancreatic ductal cells (ARIP) is associated with the development of susceptibility to cytokine-induced apoptosis
J. Mol. Endocrinol., April 1, 2005; 34(2): 367 - 376.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
C. Santangelo, A. Scipioni, L. Marselli, P. Marchetti, and F. Dotta
Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines
Eur. J. Endocrinol., March 1, 2005; 152(3): 485 - 489.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Del Guerra, R. Lupi, L. Marselli, M. Masini, M. Bugliani, S. Sbrana, S. Torri, M. Pollera, U. Boggi, F. Mosca, et al.
Functional and Molecular Defects of Pancreatic Islets in Human Type 2 Diabetes
Diabetes, March 1, 2005; 54(3): 727 - 735.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Marchetti, S. Del Guerra, L. Marselli, R. Lupi, M. Masini, M. Pollera, M. Bugliani, U. Boggi, F. Vistoli, F. Mosca, et al.
Pancreatic Islets from Type 2 Diabetic Patients Have Functional Defects and Increased Apoptosis That Are Ameliorated by Metformin
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5535 - 5541.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Marchetti, A. Antonelli, R. Lupi, L. Marselli, P. Fallahi, C. Nesti, G. Baj, and E. Ferrannini
Prolonged In Vitro Exposure to Autoantibodies Against CD38 Impairs the Function and Survival of Human Pancreatic Islets
Diabetes, December 1, 2002; 51(90003): S474 - 477.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Marchetti, R. Lupi, M. Federici, L. Marselli, M. Masini, U. Boggi, S. Del Guerra, G. Patane, S. Piro, M. Anello, et al.
Insulin Secretory Function Is Impaired in Isolated Human Islets Carrying the Gly972->Arg IRS-1 Polymorphism
Diabetes, May 1, 2002; 51(5): 1419 - 1424.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Lupi, F. Dotta, L. Marselli, S. Del Guerra, M. Masini, C. Santangelo, G. Patane, U. Boggi, S. Piro, M. Anello, et al.
Prolonged Exposure to Free Fatty Acids Has Cytostatic and Pro-Apoptotic Effects on Human Pancreatic Islets: Evidence that {beta}-Cell Death Is Caspase Mediated, Partially Dependent on Ceramide Pathway, and Bcl-2 Regulated
Diabetes, May 1, 2002; 51(5): 1437 - 1442.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society